395 related articles for article (PubMed ID: 22286761)
1. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.
Mizuno T; Murakami H; Fujii M; Ishiguro F; Tanaka I; Kondo Y; Akatsuka S; Toyokuni S; Yokoi K; Osada H; Sekido Y
Oncogene; 2012 Dec; 31(49):5117-22. PubMed ID: 22286761
[TBL] [Abstract][Full Text] [Related]
2. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.
Tanaka I; Osada H; Fujii M; Fukatsu A; Hida T; Horio Y; Kondo Y; Sato A; Hasegawa Y; Tsujimura T; Sekido Y
Oncogene; 2015 Jan; 34(1):73-83. PubMed ID: 24336325
[TBL] [Abstract][Full Text] [Related]
3. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
4. LATS2 is a tumor suppressor gene of malignant mesothelioma.
Murakami H; Mizuno T; Taniguchi T; Fujii M; Ishiguro F; Fukui T; Akatsuka S; Horio Y; Hida T; Kondo Y; Toyokuni S; Osada H; Sekido Y
Cancer Res; 2011 Feb; 71(3):873-83. PubMed ID: 21245096
[TBL] [Abstract][Full Text] [Related]
5. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation.
Matsushita A; Sato T; Mukai S; Fujishita T; Mishiro-Sato E; Okuda M; Aoki M; Hasegawa Y; Sekido Y
Oncogene; 2019 Mar; 38(11):1966-1978. PubMed ID: 30401981
[TBL] [Abstract][Full Text] [Related]
6. Targeting YAP in malignant pleural mesothelioma.
Zhang WQ; Dai YY; Hsu PC; Wang H; Cheng L; Yang YL; Wang YC; Xu ZD; Liu S; Chan G; Hu B; Li H; Jablons DM; You L
J Cell Mol Med; 2017 Nov; 21(11):2663-2676. PubMed ID: 28470935
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.
Sekido Y
Pathol Int; 2011 Jun; 61(6):331-44. PubMed ID: 21615608
[TBL] [Abstract][Full Text] [Related]
8. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
Striedinger K; VandenBerg SR; Baia GS; McDermott MW; Gutmann DH; Lal A
Neoplasia; 2008 Nov; 10(11):1204-12. PubMed ID: 18953429
[TBL] [Abstract][Full Text] [Related]
9. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.
Xiao GH; Gallagher R; Shetler J; Skele K; Altomare DA; Pestell RG; Jhanwar S; Testa JR
Mol Cell Biol; 2005 Mar; 25(6):2384-94. PubMed ID: 15743831
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line.
Zhou Z; Zhu JS; Xu ZP; Zhang Q
Mol Med Rep; 2011; 4(6):1075-82. PubMed ID: 21805037
[TBL] [Abstract][Full Text] [Related]
11. Activation of Yes-Associated Protein in Low-Grade Meningiomas Is Regulated by Merlin, Cell Density, and Extracellular Matrix Stiffness.
Tanahashi K; Natsume A; Ohka F; Motomura K; Alim A; Tanaka I; Senga T; Harada I; Fukuyama R; Sumiyoshi N; Sekido Y; Wakabayashi T
J Neuropathol Exp Neurol; 2015 Jul; 74(7):704-9. PubMed ID: 26049897
[TBL] [Abstract][Full Text] [Related]
12. A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.
Hillen H; Candi A; Vanderhoydonck B; Kowalczyk W; Sansores-Garcia L; Kesikiadou EC; Van Huffel L; Spiessens L; Nijs M; Soons E; Haeck W; Klaassen H; Smets W; Spieser SA; Marchand A; Chaltin P; Ciesielski F; Debaene F; Chen L; Kamal A; Gwaltney SL; Versele M; Halder GA
Mol Cancer Ther; 2024 Jan; 23(1):3-13. PubMed ID: 37748190
[TBL] [Abstract][Full Text] [Related]
13. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.
Miao J; Kyoyama H; Liu L; Chan G; Wang Y; Urisman A; Yang YL; Liu S; Xu Z; Bin H; Li H; Jablons DM; You L
J Cell Mol Med; 2020 Jan; 24(1):1087-1098. PubMed ID: 31755214
[TBL] [Abstract][Full Text] [Related]
15. Activation of Yap-Directed Transcription by Knockdown of Conserved Cellular Functions.
Agarinis C; Orsini V; Megel P; Abraham Y; Yang H; Mickanin C; Myer V; Bouwmeester T; Tchorz JS; Parker CN
J Biomol Screen; 2016 Mar; 21(3):269-76. PubMed ID: 26637552
[TBL] [Abstract][Full Text] [Related]
16. Blockage of glioma cell survival by truncated TEAD-binding domain of YAP.
Zhao W; Dong QF; Li LW; Yan ZF; Huo JL; Chen XY; Yang X; Li PQ; Fei Z; Zhen HN
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1713-1723. PubMed ID: 33651140
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
Zhou X; Zhang P; Han H; Lei H; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
[TBL] [Abstract][Full Text] [Related]
18. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.
Miyanaga A; Masuda M; Tsuta K; Kawasaki K; Nakamura Y; Sakuma T; Asamura H; Gemma A; Yamada T
J Thorac Oncol; 2015 May; 10(5):844-851. PubMed ID: 25902174
[TBL] [Abstract][Full Text] [Related]
19. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
20. NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition.
Garcia-Rendueles ME; Ricarte-Filho JC; Untch BR; Landa I; Knauf JA; Voza F; Smith VE; Ganly I; Taylor BS; Persaud Y; Oler G; Fang Y; Jhanwar SC; Viale A; Heguy A; Huberman KH; Giancotti F; Ghossein R; Fagin JA
Cancer Discov; 2015 Nov; 5(11):1178-93. PubMed ID: 26359368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
